Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
This article compares retirement index funds and target date funds to help you decide which aligns with your goals and timeline.
26,044 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
A price about break out in AI pricing is emerging as competition intensifies. Investors are counting on who can monet...
Pi Network unveils a new staking-focused upgrade as Pi2Day nears, designed to simplify participation for Pioneers and...
Britain’s crypto rulebook is complete, with a mandatory regime slated for late 2027. This guide explains what changed...
Gauntlet, a veteran analytics provider in the DeFi space, secured $125 million from SBI Holdings in June, signaling g...
Netflix revealed it used AI to speed production on a documentary, delivering 17 minutes of AI-enhanced footage at hal...
What could Nu Holdings look like a decade from now? This article breaks down growth catalysts, potential paths, and p...
Lawmakers push for AI safety, privacy, and energy rules. Investors weigh how regulation could affect big AI players a...
The Trade Desk jumps about 26% as OpenAI reportedly weighs a partnership to monetize ads through its platform, aided ...
Three stocks mispriced right could offer substantial upside for patient investors. This article breaks down why these...
Oil markets jump on Middle East disruption fears, signaling durable upside for energy stocks. Analysts outline who co...
A surge of early arrivals has prompted airports to change guidance, arguing that arriving too early can slow lines fo...